CN101641451A - chr8q24.21上的癌症易感性变体 - Google Patents

chr8q24.21上的癌症易感性变体 Download PDF

Info

Publication number
CN101641451A
CN101641451A CN200780046943A CN200780046943A CN101641451A CN 101641451 A CN101641451 A CN 101641451A CN 200780046943 A CN200780046943 A CN 200780046943A CN 200780046943 A CN200780046943 A CN 200780046943A CN 101641451 A CN101641451 A CN 101641451A
Authority
CN
China
Prior art keywords
cancer
allele
marker
markers
prostate cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200780046943A
Other languages
English (en)
Chinese (zh)
Inventor
尤利乌斯·格维兹门松
帕特里克·舒莱姆
奥古斯丁·孔
安德烈·马诺列斯库
劳非·阿孟达多蒂尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Decode Genetics ehf
Original Assignee
Decode Genetics ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Decode Genetics ehf filed Critical Decode Genetics ehf
Publication of CN101641451A publication Critical patent/CN101641451A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN200780046943A 2006-10-27 2007-10-26 chr8q24.21上的癌症易感性变体 Pending CN101641451A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IS8560 2006-10-27
IS8560 2006-10-27

Publications (1)

Publication Number Publication Date
CN101641451A true CN101641451A (zh) 2010-02-03

Family

ID=39060300

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200780046943A Pending CN101641451A (zh) 2006-10-27 2007-10-26 chr8q24.21上的癌症易感性变体

Country Status (13)

Country Link
US (1) US20100129799A1 (enExample)
EP (1) EP2089548A1 (enExample)
JP (1) JP5631000B2 (enExample)
CN (1) CN101641451A (enExample)
AU (1) AU2007310412B2 (enExample)
BR (1) BRPI0718322A2 (enExample)
CA (1) CA2667737A1 (enExample)
IL (1) IL198305A0 (enExample)
MX (1) MX2009004522A (enExample)
NZ (1) NZ576591A (enExample)
SG (1) SG175680A1 (enExample)
WO (1) WO2008050356A1 (enExample)
ZA (1) ZA200903173B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102304567A (zh) * 2011-04-29 2012-01-04 广州益善生物技术有限公司 一种染色体8q24区段多态性检测特异性引物和液相芯片
CN106480211A (zh) * 2016-11-24 2017-03-08 深圳市核子基因科技有限公司 一种用于检测睾丸癌易感性的试剂盒及其snp标志物

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12366585B2 (en) 2006-05-18 2025-07-22 Caris Mpi, Inc. Molecular profiling of tumors
NZ579401A (en) * 2007-02-07 2012-03-30 Decode Genetics Ehf Genetic variants contributing to risk of prostate cancer
BRPI0810071A2 (pt) 2007-04-17 2014-10-14 Santen Pharmaceutical Co Ltd Método para determinação do risco inicial de glaucoma
US8697360B2 (en) * 2007-11-30 2014-04-15 Decode Genetics Ehf. Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
WO2009085196A1 (en) * 2007-12-21 2009-07-09 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
WO2010004591A2 (en) * 2008-07-07 2010-01-14 Decode Genetics Ehf Genetic variants for breast cancer risk assessment
EP3216874A1 (en) 2008-09-05 2017-09-13 TOMA Biosciences, Inc. Methods for stratifying and annotating cancer drug treatment options
CN102232117A (zh) * 2008-10-14 2011-11-02 卡里斯Mpi公司 描绘肿瘤类型生物标志模式和特征集的基因靶和基因表达的蛋白靶
AU2010245598A1 (en) * 2009-05-08 2011-11-17 Decode Genetics Ehf Genetic variants contributing to risk of prostate cancer
WO2011004404A1 (en) * 2009-07-10 2011-01-13 Decode Genetics Ehf Genetic variants for predicting risk of glaucoma
WO2011009089A1 (en) * 2009-07-17 2011-01-20 Ordway Research Institute, Inc. SMALL NON-CODING REGULATORY RNAs AND METHODS FOR THEIR USE
US20120316218A1 (en) * 2009-07-17 2012-12-13 Glinsky Gennadi V SMALL NON-CODING REGULARTORY RNA's and METHODS FOR THEIR USE
CN102656458B (zh) 2009-10-26 2016-10-19 雅培分子公司 用于测定非小细胞肺癌预后的诊断方法
AU2010315601A1 (en) 2009-10-26 2012-05-10 Abbott Laboratories Diagnostic methods for determining prognosis of non-small cell lung cancer
WO2012029080A1 (en) * 2010-08-30 2012-03-08 Decode Genetics Ehf Sequence variants associated with prostate specific antigen levels
WO2012031207A2 (en) 2010-09-03 2012-03-08 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
EP3572528A1 (en) 2010-09-24 2019-11-27 The Board of Trustees of the Leland Stanford Junior University Direct capture, amplification and sequencing of target dna using immobilized primers
US9534256B2 (en) 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
EP3483285B1 (en) * 2011-02-09 2021-07-14 Bio-Rad Laboratories, Inc. Analysis of nucleic acids
US10233502B2 (en) 2011-06-22 2019-03-19 Indiana University Research And Technology Corporation Compositions for and methods of detecting, diagnosing, and prognosing thymic cancer
WO2013065072A1 (en) * 2011-10-30 2013-05-10 Decode Genetics Ehf Risk variants of prostate cancer
EP3024948B1 (en) 2013-07-25 2020-01-15 Bio-rad Laboratories, Inc. Genetic assays for detecting viral recombination rate
WO2017033154A1 (en) * 2015-08-27 2017-03-02 Koninklijke Philips N.V. An integrated method and system for identifying functional patient-specific somatic aberations using multi-omic cancer profiles
WO2017164699A1 (ko) * 2016-03-24 2017-09-28 서울대학교병원 (분사무소) 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발
KR101944927B1 (ko) 2016-03-24 2019-02-07 서울대학교산학협력단 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발
JP7138112B2 (ja) * 2017-02-01 2022-09-15 ファディア・アクチボラゲット 特定の特徴を有する個体において前立腺癌の存在または不存在を示すための方法
JPWO2020111169A1 (ja) * 2018-11-28 2021-11-04 国立大学法人千葉大学 多因子遺伝疾患の遺伝子検査法、及び検査キット
EP3963092A1 (en) * 2019-05-02 2022-03-09 Predictive Technology Group, Inc. Somatic cancer driver mutations in endometriosis lesions contribute to secondary cancer risk
US20230119558A1 (en) * 2020-03-06 2023-04-20 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Dna damage repair genes in cancer
KR102177222B1 (ko) * 2020-04-24 2020-11-10 유니젠바이오 주식회사 머신러닝 기반 암진단 예측 시스템
KR102177218B1 (ko) * 2020-04-24 2020-11-10 유니젠바이오 주식회사 머신러닝 기반 암진단 예측 장치
KR20250074712A (ko) 2023-11-15 2025-05-28 주식회사 바스젠바이오 전립선암 발병의 위험도를 예측하기 위한 조성물 및 이를 이용한 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5384261A (en) * 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
AU785425B2 (en) * 2001-03-30 2007-05-17 Genetic Technologies Limited Methods of genomic analysis
WO2003014143A2 (en) * 2001-08-04 2003-02-20 Whitehead Institute For Biomedical Research Haplotype map of the human genome and uses therefor
US20040023237A1 (en) * 2001-11-26 2004-02-05 Perelegen Sciences Inc. Methods for genomic analysis
US20040146870A1 (en) * 2003-01-27 2004-07-29 Guochun Liao Systems and methods for predicting specific genetic loci that affect phenotypic traits

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HAPMAP PROJECT: "Pr003657859.1 Sequence-specific sapiens variation rs16901979", 《PROBE DATABASE IN NCBI》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102304567A (zh) * 2011-04-29 2012-01-04 广州益善生物技术有限公司 一种染色体8q24区段多态性检测特异性引物和液相芯片
CN102304567B (zh) * 2011-04-29 2013-03-27 广州益善生物技术有限公司 一种染色体8q24区段多态性检测特异性引物和液相芯片
CN106480211A (zh) * 2016-11-24 2017-03-08 深圳市核子基因科技有限公司 一种用于检测睾丸癌易感性的试剂盒及其snp标志物

Also Published As

Publication number Publication date
SG175680A1 (en) 2011-11-28
AU2007310412A1 (en) 2008-05-02
AU2007310412B2 (en) 2013-02-14
US20100129799A1 (en) 2010-05-27
EP2089548A1 (en) 2009-08-19
JP5631000B2 (ja) 2014-11-26
BRPI0718322A2 (pt) 2013-11-26
CA2667737A1 (en) 2008-05-02
ZA200903173B (en) 2010-02-24
IL198305A0 (en) 2010-02-17
WO2008050356A1 (en) 2008-05-02
MX2009004522A (es) 2009-07-02
JP2010507388A (ja) 2010-03-11
NZ576591A (en) 2012-04-27

Similar Documents

Publication Publication Date Title
CN101874120B (zh) 作为用于乳腺癌风险评估、诊断、预后和治疗的标记的chr2和chr16的遗传性变型
CN101641451A (zh) chr8q24.21上的癌症易感性变体
CN101668865B (zh) 与心血管疾病相关联的遗传易感性变体
KR101374304B1 (ko) 타입 2 당뇨병의 위험에 대한 진단 마커인 ｔｃｆ7ｌ2유전자의 유전적 변이체
KR101582321B1 (ko) 심장성 부정맥의 위험 관리를 위한 유전적 마커
KR101708544B1 (ko) 세포 증식 질환을 분석하기 위한 방법 및 핵산
CA2566256C (en) Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
KR20110036608A (ko) 유방암 위험도 평가를 위한 유전적 변이
CN101772578A (zh) 作为标记物用在乳腺癌风险评估、诊断、预后和治疗中的在CHR 5p12和10q26上的遗传变异体
KR20110081807A (ko) 갑상선암의 위험도 평가를 위해 유용한 유전적 변이
CN109476698B (zh) 基于基因的炎性肠病诊断
US20090305284A1 (en) Methods for Identifying Risk of Breast Cancer and Treatments Thereof
CN101687050A (zh) 用于鉴别原发起源不明的癌的起源的方法和材料
CN102317470A (zh) 促进前列腺癌风险的遗传性变型
CA3068546A1 (en) Biomarkers for the diagnosis and treatment of fibrotic lung disease
AU2016325030A1 (en) Novel biomarkers and methods of treating cancer
WO2006022629A1 (en) Methods of identifying risk of type ii diabetes and treatments thereof
CN101631876A (zh) 2型糖尿病的遗传易感性变体
KR20090087486A (ko) 타입 ２ 당뇨병의 유전적 감수성 변이
CA2497597A1 (en) Methods for identifying subjects at risk of melanoma and treatments
TW202227102A (zh) 治療脂肪肝病之方法
WO2006022636A1 (en) Methods for identifying risk of type ii diabetes and treatments thereof
WO2006022634A1 (en) Methods for identifying risk of type ii diabetes and treatments thereof
EA048246B1 (ru) Способ лечения жировой болезни печени
CA2826522A1 (en) Genetic polymorphism in pnlpa3 associated with liver fibrosis methods of detection and uses thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned

Effective date of abandoning: 20151125

C20 Patent right or utility model deemed to be abandoned or is abandoned